🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the manufacturers of Tylenol, claiming the companies concealed alleged dangers that the drug created to children's neurological development.

The lawsuit comes a month after Former President Trump publicized an unsubstantiated connection between taking acetaminophen - alternatively called paracetamol - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against J&J, which previously sold the medication, the exclusive pain medication recommended for women during pregnancy, and Kenvue, which now manufacturers it.

In a official comment, he said they "betrayed America by making money from suffering and promoting medication regardless of the dangers."

The manufacturer says there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These companies lied for decades, deliberately risking numerous people to increase profits," the attorney general, a Republican, stated.

The company said in a statement that it was "very worried by the perpetuation of misinformation on the security of acetaminophen and the potential impact that could have on the health of US mothers and children."

On its online platform, the company also stated it had "regularly reviewed the relevant science and there is insufficient valid information that shows a established connection between taking paracetamol and autism."

Associations representing physicians and healthcare providers agree.

ACOG has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to treat pain and fever, which can create significant medical dangers if ignored.

"In more than two decades of research on the use of paracetamol in gestation, zero credible investigations has successfully concluded that the use of paracetamol in any trimester of pregnancy results in neurodevelopmental disorders in children," the group stated.

The court filing cites recent announcements from the Trump administration in arguing the medication is reportedly hazardous.

Last month, Trump caused concern from medical authorities when he instructed expectant mothers to "struggle intensely" not to consume acetaminophen when ill.

Federal regulators then published an announcement that doctors should think about restricting the consumption of Tylenol, while also stating that "a proven link" between the medication and autism spectrum disorder in young ones has remains unverified.

The Health Department head Kennedy, who oversees the Food and Drug Administration, had pledged in spring to conduct "a massive testing and research effort" that would establish the source of autism in a limited time.

But specialists cautioned that identifying a unique factor of autism - thought by researchers to be the result of a complex mix of genetic and surrounding conditions - would not be simple.

Autism is a category of enduring cognitive variation and disability that affects how individuals experience and interact with the world, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is campaigning for the Senate - alleges Kenvue and J&J "willfully ignored and attempted to silence the evidence" around acetaminophen and autism.

The case seeks to make the firms "destroy any commercial messaging" that claims acetaminophen is reliable for expectant mothers.

This legal action mirrors the complaints of a assembly of parents of children with autism and attention deficit hyperactivity disorder who took legal action against the makers of acetaminophen in two years ago.

Judicial authorities threw out the lawsuit, saying studies from the plaintiffs' authorities was inconclusive.